Norway· NO-ID_0CA1CE9E-4635-4744-B6A0-EEBB2C786C66
Lanvis
A tioguanine product containing tioguanine, registered in Norway by GlaxoSmithKline. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tioguanine is registered in 13 of 19 countries.
Countries holding a registration under ATC L01BB03 (tioguanine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Tioguanine · ATC L01BB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Tioguanine
- Manufacturer
- GlaxoSmithKline
- Country
- Norway (NO)
- ATC code
- L01BB03
- ATC class
- Tioguanine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_merkevare_idID_0CA1CE9E-4635-4744-B6A0-EEBB2C786C66
- no_varenummer27157725
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for tioguanine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tioguanine · interactions on record
434 records
- 33 severe
- 377 moderate
- 13 minor
- 11 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tioguanine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLanvis 40mg tabletsAspen Pharma Trading Ltd
- SwedenLanvis 40 mg TablettAspen Pharma Trading Limited
- SpainLANVIS 40 MG COMPRIMIDOSAspen Pharma Trading Limited
- FranceLANVIS 40 mg, comprimé sécableASPEN PHARMA TRADING (IRLANDE)
- IrelandLanvis 40mg TabletsAspen Pharma Trading Limited
- NetherlandsLanvis 40 mg tablettenAspen Pharma Trading Limited
- PolandLanvisAspen Pharma Trading Ltd.
- CanadaLANVISASPEN PHARMACARE CANADA INC.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Thioguanin Aspen
- Belgium · Lanvis
- Czechia · Lanvis
- Germany · Thioguanin Aspen
- Estonia · Lanvis
- Spain · Lanvis
- France · Lanvis
- Ireland · Lanvis
- Italy · Tioguanina
- Lithuania · Lanvis
- Netherlands · Lanvis, Thiosix
- Poland · Lanvis
- Romania · Lanvis
- Sweden · Lanvis
- Slovakia · Lanvis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d29c2d11-305c-48db-b123-578bbad50e9e GET /v1/drugs/d29c2d11-305c-48db-b123-578bbad50e9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Tioguanin",
"merkevare_id": "ID_0CA1CE9E-4635-4744-B6A0-EEBB2C786C66",
"name_form_strength": "Lanvis tab 40 mg",
"prescription_group": "C"
}See everything about tioguanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.